IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Delmar Pharmaceuticals

CUSIP: 247078108 | 3 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

Mariner, LLC10,000
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Mariner, LLC
10,000$30.0%GrowthLowOverland Park, KS2019-02-13